Cargando…

New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience

Type 2 diabetes mellitus (T2DM) has been recognized as a risk factor for severe coronavirus disease 2019 (COVID-19) infection, and COVID-19 in diabetic patients is associated with a poor prognosis. New evidence suggests that patients with T2DM may experience diabetic ketoacidosis (DKA) or hyperglyce...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Yataco, Anthony, Salcedo Davila, Emanuel A, Meza, Kelly, Harbuz-Miller, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404677/
https://www.ncbi.nlm.nih.gov/pubmed/36039206
http://dx.doi.org/10.7759/cureus.27272
_version_ 1784773692698394624
author Ramos-Yataco, Anthony
Salcedo Davila, Emanuel A
Meza, Kelly
Harbuz-Miller, Inga
author_facet Ramos-Yataco, Anthony
Salcedo Davila, Emanuel A
Meza, Kelly
Harbuz-Miller, Inga
author_sort Ramos-Yataco, Anthony
collection PubMed
description Type 2 diabetes mellitus (T2DM) has been recognized as a risk factor for severe coronavirus disease 2019 (COVID-19) infection, and COVID-19 in diabetic patients is associated with a poor prognosis. New evidence suggests that patients with T2DM may experience diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar state (HHS) if infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is limited literature on new-onset diabetes in patients infected by SARS-CoV-2 without a history of diabetes. We present a case series of three patients who developed new-onset diabetes while suffering from acute COVID-19 infection; they presented with DKA even though they had no prior history or risk factors for diabetes. They remain persistently insulin-dependent several months post-recovery.
format Online
Article
Text
id pubmed-9404677
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94046772022-08-28 New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience Ramos-Yataco, Anthony Salcedo Davila, Emanuel A Meza, Kelly Harbuz-Miller, Inga Cureus Endocrinology/Diabetes/Metabolism Type 2 diabetes mellitus (T2DM) has been recognized as a risk factor for severe coronavirus disease 2019 (COVID-19) infection, and COVID-19 in diabetic patients is associated with a poor prognosis. New evidence suggests that patients with T2DM may experience diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar state (HHS) if infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is limited literature on new-onset diabetes in patients infected by SARS-CoV-2 without a history of diabetes. We present a case series of three patients who developed new-onset diabetes while suffering from acute COVID-19 infection; they presented with DKA even though they had no prior history or risk factors for diabetes. They remain persistently insulin-dependent several months post-recovery. Cureus 2022-07-26 /pmc/articles/PMC9404677/ /pubmed/36039206 http://dx.doi.org/10.7759/cureus.27272 Text en Copyright © 2022, Ramos-Yataco et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Ramos-Yataco, Anthony
Salcedo Davila, Emanuel A
Meza, Kelly
Harbuz-Miller, Inga
New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
title New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
title_full New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
title_fullStr New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
title_full_unstemmed New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
title_short New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
title_sort new-onset and persistent insulin-dependent diabetes in patients with covid-19: a peruvian experience
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404677/
https://www.ncbi.nlm.nih.gov/pubmed/36039206
http://dx.doi.org/10.7759/cureus.27272
work_keys_str_mv AT ramosyatacoanthony newonsetandpersistentinsulindependentdiabetesinpatientswithcovid19aperuvianexperience
AT salcedodavilaemanuela newonsetandpersistentinsulindependentdiabetesinpatientswithcovid19aperuvianexperience
AT mezakelly newonsetandpersistentinsulindependentdiabetesinpatientswithcovid19aperuvianexperience
AT harbuzmilleringa newonsetandpersistentinsulindependentdiabetesinpatientswithcovid19aperuvianexperience